Custom Search

Brand Name(s): Hycamtin
CAS nº: 123948-87-8
(toh poh TEE kan)

What is Topotecan?

Topotecan belongs to the general group of chemotherapy drugs known as topoisomerase inhibitors.

It is used to treat advanced cervical and ovarian cancers as well and small cell lung cancer that has continued to grow after first–line therapy.

Topotecan works by stopping the growth of cancer cells by preventing the development of elements necessary for cell division.

See more Product Info

Latest News

BioNumerik begins Phase III ovarian cancer trials on new drug

BioNumerik Pharmaceuticals Inc. on Thursday said the first patient has begun treatment in a global...

[more]

GlaxoSmithKline gets EMEA positive opinion for Hycamtin

GlaxoSmithKline, or GSK, said Monday that oral Hycamtin (topotecan hard capsules) has received a...

[more]

Hycamtin® Improves Survival in Patients with Relapsed Small Cell Lung Cancer

According to the results of a study published in the Journal of Clinical Oncology, patients with...

[more]

Hycamtin(R) (Topotecan HCl) Indication Expanded To Include Treatment of Cervical Cancer in Combination With Chemotherapy

Of more than 40 regimens investigated1 Hycamtin® is the first to provide additional survival...

[more]

Committee for Medicinal Products for Human Use Post-authorisation Summary of Positive Opinion for Hycamtin

On 18 October 2006 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive...

[more]

Use of this site is subject to the following terms of use